Picodya introduces game-changing technology with the proven potential to empower diagnostics access worldwide.Picodya's B-Matrix, microfluidic lab-on-a-chip platform redefines diagnostics, supports simultaneous hybrid testing for both molecular and immunoassays with multiplexed syndromic panels for various sample types.

Its innovative multi-use consumables utilization allows for massive cost reduction while the minimal sample volume offers less invasive patients’ experience.The system unique and modular design supports diverse clinical settings anywhere from a large hospital systems’ laboratory through urgent care settings and physician offices as well as emerging settings such as airports, pharmacies and patients’ homes.